The Internationalization of Corporate R&D

THE INTERNATIONALIZATION OF CORPORATE R&Dthese human resources are vital in this system, efforts should be made to facilitate theirwork. Industry representatives have suggested that one way to facilitate the work ofclinical researchers is to establish one responsible actor (instead of several with differinggoals) for clinical trials. That would also facilitate contact with companies interestedin performing clinical trials.Other advantages include Sweden’s unique databanks and patient registers, which areof great value when developing medicine. Offering companies pursuing R&D inSweden access to the unique databanks may also be used as a competitive advantage.These suggestions indicate that structural changes are essential in order for Sweden toretain its position as an attractive country for pharmaceutical companies to locate R&D.165